Dashboard
Manage Tickers

HUMAHumacyte, Inc.

Nasdaq humacyte.com


$ 8.25 $ -0.37 (-4.29 %)    

Friday, 02-Aug-2024 15:59:55 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 447.95 $ -10.91 (-2.37 %)
DIA $ 397.31 $ -6.10 (-1.51 %)
SPY $ 532.92 $ -10.11 (-1.86 %)
TLT $ 98.17 $ 2.97 (3.12 %)
GLD $ 225.36 $ -0.43 (-0.19 %)
$ 8.25
$ 8.23 x 100
$ 8.25 x 100
-- - --
$ 1.96 - $ 9.97
3,430,284
na
893.03M
$ 1.54
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-13-2024 03-31-2024 10-Q
2 03-28-2024 12-31-2023 10-K
3 11-09-2023 09-30-2023 10-Q
4 08-14-2023 06-30-2023 10-Q
5 05-12-2023 03-31-2023 10-Q
6 03-24-2023 12-31-2022 10-K
7 11-10-2022 09-30-2022 10-Q
8 08-12-2022 06-30-2022 10-Q
9 05-13-2022 03-31-2022 10-Q
10 03-29-2022 12-31-2021 10-K
11 11-15-2021 09-30-2021 10-Q
12 08-16-2021 06-30-2021 10-Q
13 05-17-2021 03-31-2021 10-Q
14 02-16-2021 12-31-2020 10-K
15 11-13-2020 09-30-2020 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

8-best-performing-small-caps-in-july-find-out-which-stock-jumped-803
8 Best-Performing Small Caps In July: Find...
08/01/2024 20:54:40

Macro environment favors large-caps, but July saw impressive gains for small-caps, with Serve Robotics leading at 803% and Q32 ...

humacyte-announced-topline-results-from-v007-phase-3-trial-of-acellular-tissue-engineered-vessel-atev-in-arteriovenous-access-for-end-stage-renal-disease-patients-atev-demonstrated-superior-function-and-patency-at-6-and-12-months-vs-autogenous-fistula
Humacyte Announced Topline Results From V0...
07/31/2024 11:16:52

whats-going-on-with-huamacyte-shares-tuesday
What's Going On With Huamacyte Shares Tues...
07/16/2024 18:48:00

Humacyte has so far added Dr. John P. Bamforth and Dr. Keith Anthony to its Board of Directors, entered a license agreement wit...

why-solaredge-shares-are-trading-lower-by-12-here-are-other-stocks-moving-in-mondays-mid-day-session
Why SolarEdge Shares Are Trading Lower By ...
07/15/2024 17:23:20

btig-maintains-buy-on-humacyte-raises-price-target-to-11
BTIG Maintains Buy on Humacyte, Raises Pri...
07/15/2024 17:03:43

BTIG analyst Ryan Zimmerman maintains Humacyte (NASDAQ:HUMA) with a Buy and raises the price target from $8 to $11.

microstrategy-coinbase-robinhood-tesla-and-other-big-stocks-moving-higher-on-monday
MicroStrategy, Coinbase, Robinhood, Tesla ...
07/15/2024 15:04:09

huma---analyzing-humacytes-short-interest
(HUMA) - Analyzing Humacyte's Short Interest
07/15/2024 13:00:15

pluristyx-announces-license-agreement-with-humacyte-humacyte-to-use-pluristyxs-clinical-grade-pluribank-ipsc-line-for-manufacturing-insulin-producing-cells-for-biovascular-pancreas-product
Pluristyx Announces License Agreement with...
07/09/2024 14:07:51

Partnership Includes Access to panCELLa™ Platform for Generating Hypoimmune Cells for Clinical Implantation

cantor-fitzgerald-reiterates-overweight-on-humacyte-maintains-7-price-target
Cantor Fitzgerald Reiterates Overweight on...
07/02/2024 14:43:42

Cantor Fitzgerald analyst Kristen Kluska reiterates Humacyte (NASDAQ:HUMA) with a Overweight and maintains $7 price target.

benchmark-reiterates-buy-on-humacyte-maintains-15-price-target
Benchmark Reiterates Buy on Humacyte, Main...
07/02/2024 13:27:50

Benchmark analyst Bruce Jackson reiterates Humacyte (NASDAQ:HUMA) with a Buy and maintains $15 price target.

humacyte-shares-are-continuing-higher-after-the-company-on-monday-announced-it-was-granted-regenerative-medicine-advanced-therapy-designation-by-the-fda-for-patients-with-advanced-peripheral-artery-disease
Humacyte shares are continuing higher afte...
07/02/2024 11:11:54

why-humacyte-stock-is-trading-15-higher-monday
Why Humacyte Stock Is Trading 15% Higher M...
07/01/2024 17:39:45

Humacyte received the Food and Drug Administration's Regenerative Medicine Advanced Therapy designation for its Acellular ...

humacyte-granted-regenerative-medicine-advanced-therapy-by-fda-for-acellular-tissue-engineered-vessel-in-advanced-peripheral-artery-disease
Humacyte Granted Regenerative Medicine Adv...
07/01/2024 12:01:06

peering-into-humacytes-recent-short-interest
Peering Into Humacyte's Recent Short Interest
06/26/2024 19:30:14

humacyte-presents-preclinical-data-for-its-biovascular-pancreas-program
Humacyte Presents Preclinical Data For Its...
06/25/2024 12:14:37

– BioVascular Pancreas (BVP) product candidate is under development as a potential treatment for type 1 diabetes – – Humacyte&#...

tommy-tuberville-sells-several-large-stock-positions-makes-new-buys-heres-what-the-us-senator-is-betting-on-now
Tommy Tuberville Sells Several Large Stock...
06/17/2024 22:45:29

Senator Tommy Tuberville disclosed numerous stock trades on Friday June 14. A look at some of the key highlights.

centers-for-medicare--medicaid-services-issues-icd-10-pcs-codes-for-humacytes-human-acellular-vessel
Centers For Medicare & Medicaid Services I...
06/17/2024 12:06:27

– Four unique ICD-10-PCS codes, effective October 1, 2024, for replacement of arteries in the upper and lower extremities using...

amc-networks-louisiana-pacific-and-other-big-stocks-moving-lower-in-mondays-pre-market-session
AMC Networks, Louisiana-Pacific And Other ...
06/17/2024 11:41:51

how-is-the-market-feeling-about-humacyte
How Is The Market Feeling About Humacyte?
06/07/2024 18:30:25

why-core--main-shares-are-trading-lower-by-11-here-are-other-stocks-moving-in-tuesdays-mid-day-session
Why Core & Main Shares Are Trading Lower B...
06/04/2024 16:54:09

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

08/05/2024 Marinus Pharmaceuticals, Inc. (MRNS)

NEW CASE INVESTIGATION

Ooma Inc (OOMA) AnaptysBio Inc (ANAB)